parallax background

Patient focused, science based, quality driven:

Harnessing the power of nature, through innovation, to advance the medicinal cannabis of tomorrow.

parallax background

Patient focused, science based, quality driven:

Harnessing the power of nature, through innovation, to advance the medicinal cannabis of tomorrow.

ABOUT US

A science based and precision driven enterprise, researching phyto-based resources, found to generate permanent and positive change to the patients, and their families, suffering from a myriad of conditions that can be relieved and treated with natural products such as those derived from the cannabis plants.

ABOUT US

A science based and precision driven enterprise, researching phyto-based resources, found to generate permanent and positive change to the patients, and their families, suffering from a myriad of conditions that can be relieved and treated with natural products such as those derived from the cannabis plants.

Our Vision

Transforming and innovating Medicinal Cannabis industry to generate substantial and positive changes to the patients' lives.

Our Vision

Transforming and innovating Medicinal Cannabis industry to generate substantial and positive changes to the patients' lives.

Our company

We are a team of passionate finders, grinders and minders. Finders who are naturally curious about the scientific developments surrounding phyto-based medicine; grinders who work relentlessly, seeking best-practices, in pursuit of our vision and goals; and minders who are continuously analysing the industry, suppliers and consumer needs, to develop strategies to address the trends we see.
Piauhy is a for-profit multinational organization dedicated to the production of medicinal products derived from plants, or simply said, phyto-based medicines.
Our team includes entrepreneurs, neuroscientists, regulatory experts, production engineers, business consultants, experts in the pharmaceutical industry, investment bankers, and other specialized professionals. What unites us, is a profound interest in the pursuit of the advancement of our industry worldwide.
Our company invests in medicinal cannabis companies, including one in Uruguay, digital marketplaces for hemp food products in Chile and Australia, and our latest venture, the launch a platform in Portugal, with an initial focus on high-grade medicinal cannabis products.
We are a precision driven enterprise, researching phyto-based resources to bring about permanent and positive change to people’s lives.

Our Objective

We are a precision driven enterprise, researching phyto-based resources to bring about permanent and positive change in people’s lives.

Our Mission

Our mission is to provide patients with the highest quality medicine for the effective treatment of diseases such as neuropathies, pain management, gastrointestinal disorders among others. We plan to achieve this by using our accumulated business and scientific acumen combined with continuous association with the various stakeholder groups, endless pursuit of excellence in R&D and in strict adherence to local laws and regulation.

Innovative Approach

Our innovative approach, backed by pioneering research in the field, is the essence of the vision of our company and projects.



Scientific Bases

A science based and precision driven enterprise, researching phyto-based resources, found to generate permanent and positive change to the patients.



European GMP Quality

Approved plans to implement GMP pharmaceutical facility in Portugal.



Patient Focus

Patient Focus & Care: meeting patient needs is the primary focus. Provide patients with the highest quality medicine for the effective treatment of diseases.



Personalized Medicine

Committed to produce high quality and personalized medicine treatment based on genetics and epigenetics information.



Innovative Approach

Our innovative approach, backed by pioneering research in the field, is the essence of the vision of our company and projects.



Scientific Bases

A science based and precision driven enterprise, researching phyto-based resources, found to generate permanent and positive change to the patients.



European GMP Quality

Approved plans to implement GMP pharmaceutical facility in Portugal.



Patient Focus

Patient Focus & Care: meeting patient needs is the primary focus. Provide patients with the highest quality medicine for the effective treatment of diseases.



Personalized Medicine

Committed to produce high quality and personalized medicine treatment based on genetics and epigenetics information.


OUR TEAM

OUR TEAM

Tomás García Navarro

General Counsel


Master in Company Legal Advice & Coach Master. President of the Healthcare & life Sciences Commission in AIJA, international Association of Young Lawyers

Joaquim Gomes

Security Director


Joaquim Gomes is a Colonel (Ret.) from GNR (Portuguese Gendarmerie) after more than 3 decades of duty. He has a degree in International Relations and a postgraduate degree in Civil Crisis Management and another one in Security Management.

Antônio Fortes, PhD

Investment Advisor


Hedge fund portfolio manager with a PhD in neurosciences

Raphael Pinaud, PhD

Scientific Advisor


Investment banker with a PhD in molecular biology

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

OUR ECOSYSTEM

 
 
Investor